- Investing Ideas
- /
- French Pharmaceuticals & Biotech Financially Fit Penny Stocks
French Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
5
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AELIS | €2.14 | 7.0% | -83.7% | €29.1m | €9.10 | PS2.7x | E33.8% | n/a | ||
ABNX | €1.21 | -0.3% | -1.3% | €42.0m | €11.50 | PS8.7x | E-23.4% | n/a | ||
ALVAL | €1.55 | 12.0% | -68.2% | €24.5m | €6.35 | PS46.4x | E59.3% | n/a | ||
IPH | €1.89 | -1.6% | -31.5% | €153.0m | €6.14 | PS4.5x | E42.4% | n/a | ||
ALGEN | €3.94 | 5.1% | -13.4% | €35.5m | n/a | PE28.3x | n/a | n/a |
Page 1 of 1